GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PreveCeutical Medical Inc (OTCPK:PRVCF) » Definitions » YoY EBITDA Growth

PRVCF (PreveCeutical Medical) YoY EBITDA Growth : 0.00% (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is PreveCeutical Medical YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. PreveCeutical Medical's YoY EBITDA Growth for the quarter that ended in Sep. 2024 was 0.00%.

PreveCeutical Medical's EBITDA per Share for the three months ended in Sep. 2024 was $0.00.

PreveCeutical Medical YoY EBITDA Growth Historical Data

The historical data trend for PreveCeutical Medical's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PreveCeutical Medical YoY EBITDA Growth Chart

PreveCeutical Medical Annual Data
Trend Jul15 Jul16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only 80.77 - 60.00 - 50.00

PreveCeutical Medical Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 100.00 - - - -

PreveCeutical Medical YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

PreveCeutical Medical's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(-0.001--0.002)/ | -0.002 |
=50.00 %

PreveCeutical Medical's YoY EBITDA Growth for the quarter that ended in Sep. 2024 is calculated as:

YoY EBITDA Growth (Q: Sep. 2024 )
=(EBITDA per Share (Q: Sep. 2024 )-EBITDA per Share (Q: Sep. 2023 )) / | EBITDA per Share (Q: Sep. 2023 )) |
=(-0--0)/ | -0 |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PreveCeutical Medical YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of PreveCeutical Medical's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

PreveCeutical Medical Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PreveCeutical Medical Inc (OTCPK:PRVCF) » Definitions » YoY EBITDA Growth
Comparable Companies
XCNQ:PHRM TSXV:IBO TSXV:IBT XCNQ:BIOV TSXV:RKV XCNQ:CMND TSXV:KNE XCNQ:NIRV XCNQ:TELI XCNQ:BRAX OCSE:NOVO B ASX:CSL REGN VRTX MRNA XKRX:207940 BNTX HKSE:02269 SGEN SZSE:300122
Traded in Other Exchanges
18H:Germany PREV:Canada
Address
5428 Marine Drive, Suite 2500, Vancouver, BC, CAN, V7W 2R2
Website
https://www.preveceutical.com
PreveCeutical Medical Inc is a health sciences company. Its principal business activity is the development of innovative options for preventive and curative therapies utilizing organic and nature-identical products. The company is engaged in licensing, branding, and marketing nutraceutical and wellness products.